MM-02-08
MM-02-08 is a BRD4 PROTAC degrader with a DC50 of approximately 10 nM. MM-02-08 mediates mono-ubiquitination and poly-ubiquitination modifications of target proteins without impairing cell viability. MM-02-08 is applicable to related research on triple-negative breast cancer, prostate cancer, and other diseases.
(Pink: BRD4 ligand (HY-78695); Blue: DDB1 ligand (HY-175890); Black: linker (HY-W004710)).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C49H48Cl2N8O4S
- Masse moléculaire:915.93
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform PROTACs
More
Activité biologique
|
BRD4 10 nM (DC50) |
MM-02-08 (24 h) simultaneously degrades both the short and long isoforms of BRD4 in MDA-MB-231 cells, and this degradation process depends on the functions of the proteasome, ubiquitin-like modification, and DDB1[1].
MM-02-08 selectively degrades the short isoform of BRD4 in HEK293T cells via a proteasome-, NEDDylation- and DDB1-dependent mechanism[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Masse moléculaire 915.93
-
Formule C49H48Cl2N8O4S
-
SMILES
O=C(NCCCCCNC(C[C@H]1C2=NN=C(C)N2C(SC(C)=C3C)=C3C(C4=CC=C(Cl)C=C4)=N1)=O)C5=CC=C(C6CC(C7=CC(OCC8=CC=CC=C8)=CC=C7)=NN6C(CCl)=O)C=C5
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)